Lazard Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-642
Closed -$44K – 2594
2024
Q3
$44K Hold
642
– – ﹤0.01% 1943
2024
Q2
$43K Sell
642
-57
-8% -$3.84K ﹤0.01% 1956
2024
Q1
$48K Sell
699
-48
-6% -$3.24K ﹤0.01% 1727
2023
Q4
$46K Buy
747
+73
+11% +$4.08K ﹤0.01% 1908
2023
Q3
$37K Hold
674
– – ﹤0.01% 1945
2023
Q2
$34K Hold
674
– – ﹤0.01% 1951
2023
Q1
$36K Sell
674
-5,828
-90% -$340K ﹤0.01% 1901
2022
Q4
$406K Buy
6,502
+674
+12% +$44.7K ﹤0.01% 1159
2022
Q3
$410K Buy
+5,828
New +$402K ﹤0.01% 1134
2022
Q2
– Sell
-189
Closed -$11K – 2615
2022
Q1
$11K Sell
189
-666
-78% -$35.9K ﹤0.01% 2131
2021
Q4
$47K Buy
855
+135
+19% +$8.25K ﹤0.01% 1772
2021
Q3
$46K Sell
720
-788
-52% -$53.8K ﹤0.01% 1721
2021
Q2
$95K Buy
1,508
+733
+95% +$43.3K ﹤0.01% 1367
2021
Q1
$46K Buy
+775
New +$42.1K ﹤0.01% 1476

Other funds holding AXNX

Lazard Asset Management's AXNX Position: Q4 2024 in Review

Lazard Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 642 shares — an estimated $44K sold.

Lazard Asset Management first reported a position in AXNX in Q1 2021 and held it in 14 quarters. The position peaked at $410K in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Lazard Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 642 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $44K.
  • Lazard Asset Management first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
  • Lazard Asset Management's Axonics, Inc. Common Stock position peaked at $410K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.